AGENUS INC Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
AGENUS INC (AGEN) reported Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent of 60.00% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent · last filed 2017-03-16
- AGENUS INC defined contribution plan, maximum annual contributions per employee, percent for fiscal 2016 was 60.00%, a 0.00% change from fiscal 2015.
- AGENUS INC defined contribution plan, maximum annual contributions per employee, percent for fiscal 2015 was 60.00%, a 0.00% change from fiscal 2014.
- AGENUS INC defined contribution plan, maximum annual contributions per employee, percent for fiscal 2014 was 60.00%, a 0.00% change from fiscal 2013.
- AGENUS INC defined contribution plan, maximum annual contributions per employee, percent for fiscal 2013 was 60.00%.
| Period end | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 12 month |
|---|---|
| 2016-12-31 | 60.00% 10-K · filed 2017-03-16 |
| 2015-12-31 | 60.00% 10-K · filed 2016-03-15 |
| 2014-12-31 | 60.00% 10-K · filed 2015-03-16 |
| 2013-12-31 | 60.00% 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |